-
公开(公告)号:US20190015397A1
公开(公告)日:2019-01-17
申请号:US16065932
申请日:2017-01-19
申请人: UNIVERSITÉ DE BORDEAUX , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX
发明人: Marie-Élise TRUCHETET , Cécile CONTIN-BORDES , Patrick BLANCO , Thierry SCHAEVERBEKE , Thomas BARNETCHE
IPC分类号: A61K31/4365 , C07K16/28 , A61P37/06
摘要: Some embodiments are directed to a substance that inhibits P2Y12 receptor for use in the preventive treatment of systemic sclerosis in patients with Raynaud's phenomenon and a dysimmunity.